Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Get Free Report) CAO Sean Thomas Willson sold 250 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $64.32, for a total transaction of $16,080.00. Following the transaction, the chief accounting officer directly owned 18,288 shares in the company, valued at $1,176,284.16. The trade was a 1.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.

Vivmark Residential Common Shares of Beneficial Interest Stock Up 0.6%

NYSE VMRK traded up $0.38 during mid-day trading on Wednesday, reaching $64.41. 6,131,899 shares of the stock were exchanged, compared to its average volume of 4,406,111. The firm has a market cap of $24.15 billion, a P/E ratio of 15.77, a price-to-earnings-growth ratio of 5.37 and a beta of 0.73. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.19 and a current ratio of 0.19. Vivmark Residential Common Shares of Beneficial Interest has a 1-year low of $57.57 and a 1-year high of $71.50.

Vivmark Residential Common Shares of Beneficial Interest News Summary

Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:

• Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and trimmed its price target only slightly, from $79.00 to $78.50. The target remains well above the recent trading level, signaling continued confidence in Vivmark’s potential. Benzinga article
• Positive Sentiment: Evercore initiated coverage with an “in-line” rating and a $72.00 price target. Although not an outright bullish rating, the target indicates potential appreciation and adds institutional research coverage. Tickerreport article
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast from $4.06 to $4.07, FY2027 EPS from $4.20 to $4.21, and Q1 2027 EPS from $1.00 to $1.02. These increases suggest slightly improved expectations for near- and medium-term profitability.
• Neutral Sentiment: The analyst consensus still projects steady earnings progression, including approximately $4.40 in FY2028 EPS, but the revisions are small and do not represent a major change to Vivmark’s outlook.
• Negative Sentiment: Zacks lowered estimates for Q3 2026, Q2 2027, Q3 2027, Q1 2028, and FY2028. The FY2028 forecast declined from $4.43 to $4.40, indicating modest pressure on longer-term earnings expectations.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on VMRK shares. Evercore started coverage on Vivmark Residential Common Shares of Beneficial Interest in a research report on Tuesday. They issued an "in-line" rating and a $72.00 price objective for the company. Stifel Nicolaus lowered their price target on Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a "buy" rating for the company in a report on Wednesday. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $75.25.

Check Out Our Latest Report on Vivmark Residential Common Shares of Beneficial Interest

About Vivmark Residential Common Shares of Beneficial Interest

(Get Free Report)

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.

Recommended Stories

• Five stocks we like better than Vivmark Residential Common Shares of Beneficial Interest
• Bloom Energy’s AI Surge Meets a Valuation Reality Check
• Target Is Winning Shoppers Back—Can the Rally Reach $180?
• IonQ’s Space Contract Points to a New Frontier for Quantum Investors
• Is Apple’s AI Strategy Smarter Than Skeptics Think?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vivmark Residential Common Shares of Beneficial Interest Right Now?

Before you consider Vivmark Residential Common Shares of Beneficial Interest, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivmark Residential Common Shares of Beneficial Interest wasn't on the list.

While Vivmark Residential Common Shares of Beneficial Interest currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here